Skip to content

N. Cardoner

2 papers in the library · publishing 2026

Papers

Sort Most recent Most cited

Long term efficacy and safety of GH001 in patients with treatment-resistant depression

European Psychiatry June 1, 2026 Eduard Vieta, Bernhard T Baune, N. Cardoner et al.

Introduction Treatment-resistant depression (TRD), a persistent condition impacting up to 30% of patients with major depressive disorder, carries substantial personal and economic burden. There remains an unmet need for therapies that provide both rapid and durable improvements in TRD. Preliminary clinical trials indicate that GH001, a synthetic, inhalable formulation of mebufotenin, has the...